Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Adherex Eniluracil Phase III To Start Mid ’07; Firm Outlines Fixes For Failed GSK Trials

Dec 15 2005

• By Pharmaceutical Approvals Monthly

Related Content

Adherex Licenses GSK’s Eniluracil, Estimates Oncologic’s Potential At $1 Bil.

Aug 15 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window